Three patterns of p16 expression were identified: (1) a total loss of expression (Figure 1A), (2) a focal positive expression in a variable amount of tumor cells (Figure 1B), and (3) an intense and diffuse positivity throughout samples (Figure 1C). Here, CDKN2A is linked to neoplasm.